BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 30, 2017
View Archived Issues
Celgene offers product and pipeline update for third quarter 2017
Read More
Bristol-Myers Squibb offers product and pipeline update from third quarter 2017
Read More
Mitobridge describes novel PPAR-delta agonists
Read More
JCR Pharmaceuticals to initiate development of JR-171 for Hurler Syndrome
Read More
Allergan presents new fMet-Leu-Phe receptor modulators
Read More
Boehringer Ingelheim discovers new orexin receptor type 1 antagonists
Read More
Novel proto-oncogene c-Ret inhibitors identified at Cancer Research Technology
Read More
DS-5010 demonstrates potent antitumor activity in vitro and in vivo
Read More
New antibacterials patented by Actelion Pharmaceuticals
Read More
FDA grants priority review to elagolix for endometriosis-associated pain
Read More
Successful tumor imagining with novel somatostatin receptor antagonist 68Ga-NODAGA-LM3
Read More
Fostemsavir reduces HIV-1 viral load in heavily treatment-experienced patients
Read More
Phase I trial to evaluate Curevac's immunomodulator CV-8102
Read More
Sumitomo Dainippon and Poxel sign strategic partnership for imeglimin in Asias countries
Read More
Merck & Co. withdraws European application for Keytruda in first-line metastatic non-squamous NSCLC
Read More
Novartis proposes to acquire Advanced Accelerator Applications
Read More
Argenx initiates phase I trial of subcutaneous formulation of ARGX-113
Read More
Clinical data for maralixibat in patients with Alagille syndrome presented
Read More
Janssen conducts phase 0 exploratory trial of [18F]MNI-1020 as imaging marker for tau protein
Read More
Reversible 18F-labeled tracer GEH200431-B a potential candidate for MAO-B imaging in humans
Read More
Rgenix releases preliminary phase Ia/b data on RGX-104 in advanced cancer
Read More
[Ga68]PSMA bimodal probe for radio- and fluorescence-guided surgery of prostate cancer
Read More
Longevity Biotech awarded grant to evaluate LBT-3627 for multiple sclerosis
Read More
New phase I study at Stanford explores CD19/CD22-CAR T cells for B-cell malignancies
Read More
Mereo agrees with AstraZeneca on exclusive license and option to acquire AZD-9668
Read More
New ATOM consortium aims to reduce preclinical cancer drug discovery time
Read More
Astellas establishes screening collaboration agreement with MMV for malaria
Read More
Daiichi Sankyo and Glycotope sign option agreement on ADC collaboration and licensing
Read More